TY - JOUR
T1 - The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family
AU - Gallo, Maura
AU - Frangipane, Francesca
AU - Cupidi, Chiara
AU - De Bartolo, Matteo
AU - Turone, Sabina
AU - Ferrari, Camilla
AU - Nacmias, Benedetta
AU - Grimaldi, Giuliana
AU - Laganà, Valentina
AU - Colao, Rosanna
AU - Bernardi, Livia
AU - Anfossi, Maria
AU - Conidi, Maria Elena
AU - Vasso, Franca
AU - Curcio, Sabrina Anna Maria
AU - Mirabelli, Maria C.
AU - Smirne, Nicoletta
AU - Torchia, Giusi
AU - Muraca, Maria Gabriella
AU - Puccio, Gianfranco
AU - Di Lorenzo, Raffaele
AU - Piccininni, Maristella
AU - Tedde, Andrea
AU - Maletta, Raffaele Giovanni
AU - Sorbi, Sandro
AU - Bruni, Amalia Cecilia
PY - 2017/5
Y1 - 2017/5
N2 - We identified the novel PSEN1 pathogenic mutation M84V in 3 patients belonging to a large kindred affected by autosomal dominant Alzheimer's disease (AD). The clinical phenotype was characterized by early onset dementia in 14 affected subjects over 3 generations. Detailed clinical, imaging and genetic assessment was performed. We highlighted the presence of unusual symptoms such as frontal executive syndrome, psychosis and spastic paraparesis in these patients. Spastic paraparesis has been reported in other PSEN1 mutations in adjacent codons, suggesting that the position of the genetic defect may affect the clinical expression, although this phenotype can occur in mutations throughout the whole PSEN1 gene. Brain magnetic resonance imaging showed diffuse cortical atrophy, but also atrophy of cerebellar lobules, mainly involving Crus I, in 2 patients without cerebellar motor deficits. These neuroimaging results were consistent with recent findings about the association between sporadic AD and distinct and circumscribed cerebellar atrophy. The present work acknowledged the novel PSEN1 pathogenic mutation M84V and might contribute to the ongoing debate about the involvement of cerebellum in AD.
AB - We identified the novel PSEN1 pathogenic mutation M84V in 3 patients belonging to a large kindred affected by autosomal dominant Alzheimer's disease (AD). The clinical phenotype was characterized by early onset dementia in 14 affected subjects over 3 generations. Detailed clinical, imaging and genetic assessment was performed. We highlighted the presence of unusual symptoms such as frontal executive syndrome, psychosis and spastic paraparesis in these patients. Spastic paraparesis has been reported in other PSEN1 mutations in adjacent codons, suggesting that the position of the genetic defect may affect the clinical expression, although this phenotype can occur in mutations throughout the whole PSEN1 gene. Brain magnetic resonance imaging showed diffuse cortical atrophy, but also atrophy of cerebellar lobules, mainly involving Crus I, in 2 patients without cerebellar motor deficits. These neuroimaging results were consistent with recent findings about the association between sporadic AD and distinct and circumscribed cerebellar atrophy. The present work acknowledged the novel PSEN1 pathogenic mutation M84V and might contribute to the ongoing debate about the involvement of cerebellum in AD.
KW - Alzheimer's disease
KW - Cerebellum
KW - M84V
KW - Presenilin 1 mutation
KW - Spastic paraparesis
UR - http://www.scopus.com/inward/record.url?scp=85019953185&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85019953185&partnerID=8YFLogxK
U2 - 10.1016/j.neurobiolaging.2017.04.017
DO - 10.1016/j.neurobiolaging.2017.04.017
M3 - Article
AN - SCOPUS:85019953185
JO - Neurobiology of Aging
JF - Neurobiology of Aging
SN - 0197-4580
ER -